AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Iveda Solutions, Inc.

$0.28 -$0.59 (-67.36%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$0.29
Day Range
$0.28$0.3
Year Range
$0.21$2.24
Market Cap
3.29M
AVG Volume
8.01M
Trailing/Forward PE
-0.34/-
PEG ratio
-0.01
Dividend Yield
-
Next Earnings Date
2026-12-02
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
02M4M6M8M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IVDA Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q24.57M
26 Q15.3M
25 Q45.28M
25 Q36.4M
25 Q27.14M
25 Q17.15M
24 Q46.02M
24 Q35.31M
24 Q23.78M
24 Q14.64M
Net Income (USD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IVDA Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-3.17M
26 Q1-2.94M
25 Q4-3.2M
25 Q3-3.4M
25 Q2-3.74M
25 Q1-3.77M
24 Q4-4.27M
24 Q3-3.54M
24 Q2-3.82M
24 Q1-3.97M
Operating Income (USD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IVDA Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-3.13M
26 Q1-2.96M
25 Q4-3.23M
25 Q3-3.38M
25 Q2-3.76M
25 Q1-3.84M
24 Q4-4.34M
24 Q3-3.68M
24 Q2-3.98M
24 Q1-4.19M
EBITDA (USD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IVDA EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2-3.01M
26 Q1-2.85M
25 Q4-3.11M
25 Q3-3.27M
25 Q2-3.62M
25 Q1-3.69M
24 Q4-4.16M
24 Q3-3.49M
24 Q2-3.77M
24 Q1-3.99M
Cash Flows (USD) · TTM
-8M-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IVDA Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-2.93M
26 Q1-1.5M
25 Q4-694.3K
25 Q3-1.66M
25 Q2-2.24M
25 Q1-3.25M
24 Q4-4.42M
24 Q3-4.19M
24 Q2-6.2M
24 Q1-4.78M
EPS (USD) · TTM
-2-1.5-1-0.5024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IVDA EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-0.84
26 Q1-0.97
25 Q4-1.08
25 Q3-1.2
25 Q2-1.39
25 Q1-1.49
24 Q4-1.85
24 Q3-1.75
24 Q2-1.9
24 Q1-1.98
Expenses (USD) · TTM
-2M02M4M6MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IVDA Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2616.64K
26 Q1-887.02K
25 Q4-823.93K
25 Q33.5M
25 Q23.48M
25 Q15.06M
24 Q45.64M
24 Q35.17M
24 Q25.7M
24 Q15.85M
Shares Outstanding (USD) · TTM
-400K-300K-200K-100K0100KBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IVDA Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-388K
26 Q1-388K
25 Q4-376K
25 Q3-97K
25 Q2-97K
25 Q1-97K
24 Q4-93.31K
24 Q3-242.16K
24 Q2-242.16K
24 Q1-242.16K
Employee Count
0102030402011201220132014201520212022202320242025
IVDA Employee Count by quarter
PeriodEmployee Count
20257
20247
20237
20227
202110
201513
201424
201333
201232
201131
Free Cash Flow Yield
-250%-200%-150%-100%-50%0%med -68.19%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IVDA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-87.35%
Sep 26-86.89%
Sep 26-82.03%
Aug 26-85.22%
Aug 26-73.68%
Aug 26-58.23%
Aug 26-160.98%
Jul 26-195.23%
Jul 26-202.89%
Jul 26-188.84%
Jul 26-166.44%
Jul 26-142.73%
Jun 26-147.01%
Jun 26-114.19%
Jun 26-174.79%
Jun 26-163.45%
May 26-123.99%
May 26-153.44%
May 26-154.89%
May 26-69.93%
May 26-75.28%
Apr 26-76.19%
Apr 26-79.98%
Apr 26-89.22%
Apr 26-87.41%
Mar 26-222.06%
Mar 26-182.4%
Mar 26-183.88%
Mar 26-175.01%
Feb 26-183.75%
Feb 26-184.56%
Feb 26-161.51%
Feb 26-119.1%
Jan 26-61.85%
Jan 26-62.63%
Jan 26-52.84%
Jan 26-57.68%
Jan 26-62.56%
Dec 25-60.83%
Dec 25-56.76%
Dec 25-52.33%
Dec 25-45.74%
Nov 25-48.6%
Nov 25-62.13%
Nov 25-68.78%
Nov 25-89.78%
Oct 25-61.25%
Oct 25-59.41%
Oct 25-63.21%
Oct 25-60.78%
Oct 25-41.58%
Sep 25-65.84%
Sep 25-51.3%
Sep 25-54.49%
Sep 25-53.38%
Aug 25-49.38%
Aug 25-47.03%
Aug 25-46.48%
Aug 25-63.55%
Aug 25-61.52%
Jul 25-56.42%
Jul 25-51.64%
Jul 25-52.81%
Jul 25-55.08%
Jun 25-60.88%
Jun 25-64.98%
Jun 25-59.01%
Jun 25-47.8%
May 25-53.8%
May 25-56.15%
May 25-60.24%
May 25-67.59%
May 25-70%
Apr 25-57.48%
Apr 25-65.08%
Apr 25-77.61%
Apr 25-82.46%
Mar 25-83.86%
Mar 25-66.86%
Mar 25-84.94%
Mar 25-86.05%
Feb 25-88.75%
Feb 25-71.19%
Feb 25-61.85%
Feb 25-63.23%
Jan 25-55.59%
Jan 25-48.51%
Jan 25-46.9%
Jan 25-44.57%
Jan 25-35.34%
Dec 24-35.79%
Dec 24-67.09%
Dec 24-96.07%
Dec 24-106.4%
Nov 24-108.74%
Nov 24-92.05%
Nov 24-141.37%
Nov 24-226.27%
Nov 24-206.39%
Oct 24-188.56%
Price to Sales
0123med 0.65Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IVDA Price to Sales by quarter
PeriodPrice to Sales
Sep 260.73
Sep 260.74
Sep 260.78
Aug 260.75
Aug 260.87
Aug 261.1
Aug 260.18
Jul 260.14
Jul 260.14
Jul 260.15
Jul 260.17
Jul 260.2
Jun 260.19
Jun 260.25
Jun 260.16
Jun 260.17
May 260.23
May 260.18
May 260.18
May 260.19
May 260.17
Apr 260.17
Apr 260.16
Apr 260.15
Apr 260.15
Mar 260.12
Mar 260.14
Mar 260.14
Mar 260.15
Feb 260.14
Feb 260.14
Feb 260.16
Feb 260.22
Jan 260.42
Jan 260.41
Jan 260.49
Jan 260.45
Jan 260.41
Dec 250.43
Dec 250.46
Dec 250.5
Dec 250.57
Nov 250.53
Nov 250.42
Nov 250.38
Nov 250.35
Oct 250.51
Oct 250.53
Oct 250.5
Oct 250.52
Oct 250.75
Sep 250.48
Sep 250.61
Sep 250.58
Sep 250.59
Aug 250.64
Aug 250.67
Aug 250.68
Aug 250.71
Aug 250.74
Jul 250.81
Jul 250.88
Jul 250.86
Jul 250.82
Jun 250.75
Jun 250.7
Jun 250.77
Jun 250.95
May 250.84
May 250.81
May 250.75
May 251.09
May 251.05
Apr 251.28
Apr 251.13
Apr 251.02
Apr 250.96
Mar 250.94
Mar 251.18
Mar 250.93
Mar 250.92
Feb 250.89
Feb 251.11
Feb 251.28
Feb 251.25
Jan 251.42
Jan 251.63
Jan 251.68
Jan 251.77
Jan 252.23
Dec 242.2
Dec 241.18
Dec 240.82
Dec 240.74
Nov 240.73
Nov 240.86
Nov 240.56
Nov 240.73
Nov 240.79
Oct 240.87
Price to Book
01234med 0.85Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IVDA Price to Book by quarter
PeriodPrice to Book
Sep 260.62
Sep 260.62
Sep 260.66
Aug 260.64
Aug 260.74
Aug 260.93
Aug 260.16
Jul 260.13
Jul 260.13
Jul 260.14
Jul 260.15
Jul 260.18
Jun 260.17
Jun 260.22
Jun 260.15
Jun 260.16
May 260.21
May 260.17
May 260.16
May 260.21
May 260.19
Apr 260.19
Apr 260.18
Apr 260.16
Apr 260.17
Mar 260.2
Mar 260.24
Mar 260.24
Mar 260.25
Feb 260.24
Feb 260.24
Feb 260.27
Feb 260.37
Jan 260.71
Jan 260.7
Jan 260.83
Jan 260.76
Jan 260.7
Dec 250.72
Dec 250.78
Dec 250.84
Dec 250.96
Nov 250.91
Nov 250.71
Nov 250.64
Nov 251.69
Oct 252.47
Oct 252.55
Oct 252.4
Oct 252.49
Oct 253.64
Sep 252.3
Sep 252.95
Sep 252.78
Sep 252.84
Aug 253.07
Aug 253.22
Aug 253.26
Aug 253
Aug 253.1
Jul 253.38
Jul 253.7
Jul 253.62
Jul 253.47
Jun 253.14
Jun 252.94
Jun 253.24
Jun 254
May 253.55
May 253.4
May 253.17
May 252.61
May 252.52
Apr 253.07
Apr 252.71
Apr 250.98
Apr 250.92
Mar 250.9
Mar 251.13
Mar 250.89
Mar 250.88
Feb 250.85
Feb 251.06
Feb 251.22
Feb 251.2
Jan 251.36
Jan 251.56
Jan 251.61
Jan 251.7
Jan 252.14
Dec 242.11
Dec 241.13
Dec 240.79
Dec 240.71
Nov 240.7
Nov 240.82
Nov 240.54
Nov 240.65
Nov 240.71
Oct 240.78
Iveda Solutions, Inc.
IVDA
Stockpicker

Video analysis: IVDA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: IVDA

NASDAQ Grants Iveda Additional 180-Day Period to Regain Minimum Bid Price Compliance

gurufocus.com · 9 Sep 2026

NASDAQ Grants Iveda Additional 180-Day Period to Regain Minimum Bid Price Compliance

Iveda (NASDAQ: IVDA),a global provider of AI-powered video intelligence, smart infrastructure and connected technologies, today announced that The Nasdaq Stoc

NASDAQ Grants Iveda Additional 180-Day Period to Regain Minimum Bid Price Compliance

businesswire.com · 9 Sep 2026

NASDAQ Grants Iveda Additional 180-Day Period to Regain Minimum Bid Price Compliance

MESA, Ariz.--(BUSINESS WIRE)--Iveda® (NASDAQ: IVDA),a global provider of AI-powered video intelligence, smart infrastructure and connected technologies, today announced that The Nasdaq Stock Market has granted Iveda an additional 180-calendar-day period, through March 1, 2027, to regain compliance with Nasdaq's $1.00 minimum bid price requirement under Listing Rule 5550(a)(2). Nasdaq granted the additional compliance period after determining that Iveda satisfied the continued-listing requiremen.

IvedaAir Draws Fortune 500 Defense and Government Interest Following Launch, Advances Toward Fall Flight Demonstration

businesswire.com · 2 Sep 2026

IvedaAir Draws Fortune 500 Defense and Government Interest Following Launch, Advances Toward Fall Flight Demonstration

MESA, Ariz.--(BUSINESS WIRE)--Iveda® (NASDAQ: IVDA), a global provider of AI-powered smart city and public safety technologies, today announced growing commercial and government interest in IvedaAir, its newly launched line of AI-powered Rotary Wing Unmanned Aircraft Systems (RUAS), as the company advances discussions with prospective users and strategic partners ahead of an invitation-only flight demonstration in Arizona this fall. Following IvedaAir's unveiling on National Aviation Day on Aug.

IVDA Stock Declines 43.4% as Q2 Loss Widens, Revenues Fall Y/Y

zacks.com · 28 Aug 2026

IVDA Stock Declines 43.4% as Q2 Loss Widens, Revenues Fall Y/Y

Iveda Solutions' Q2 revenues drop 48% y/y and its net loss widens 41%, while stronger contract margins lift the gross margin to 55%.

Iveda Launches IvedaAir: Latest RUAS Line Featuring a Gas-Powered Smart Drone, Bringing AI-Powered Aerial Intelligence to Public Safety, Maritime Security, and Emergency Response Missions

businesswire.com · 19 Aug 2026

Iveda Launches IvedaAir: Latest RUAS Line Featuring a Gas-Powered Smart Drone, Bringing AI-Powered Aerial Intelligence to Public Safety, Maritime Security, and Emergency Response Missions

MESA, Ariz.--(BUSINESS WIRE)--Iveda® (NASDAQ: IVDA), a global leader in AI-powered smart city and public safety technologies, today announced the launch of IvedaAir, their latest line of autonomous unmanned helicopters engineered to deliver real-time aerial intelligence for public safety, maritime, and emergency response operations. Unlike conventional quadcopter drones, the IvedaAir line's helicopter-form design provides the endurance, stability, and payload flexibility required for real-world.

GlobalMed® and Iveda Partner to Bring Intelligent, Mission-Ready Technology to Government Agencies

businesswire.com · 12 Aug 2026

GlobalMed® and Iveda Partner to Bring Intelligent, Mission-Ready Technology to Government Agencies

MESA, Ariz.--(BUSINESS WIRE)--Iveda® (NASDAQ: IVDA), a global provider of cloud-based AI video search, surveillance, and smart infrastructure technologies, today announced a strategic partnership with GlobalMed®, a leader in digital health solutions and federal healthcare delivery. The partnership combines GlobalMed's established virtual-care ecosystem and government expertise with Iveda's AI-powered situational awareness technologies to deliver more comprehensive, intelligent solutions for gov.

Iveda Leads the Way in EU AI Act Readiness for Europe's $18B Video Intelligence Industry

businesswire.com · 5 Aug 2026

Iveda Leads the Way in EU AI Act Readiness for Europe's $18B Video Intelligence Industry

MESA, Ariz.--(BUSINESS WIRE)--Iveda® (NASDAQ: IVDA)––the global leader in AI-driven video analytics and IoT-based intelligent solutions, today announced the completion of a comprehensive European Union Artificial Intelligence Act readiness initiative, positioning IvedaAI for continued responsible deployment as the company expands across Europe. The initiative combines a documented risk-classification assessment with an extensive governance framework addressing human oversight, transparency, dat.

Primion and Iveda Partner to Bring AI Vision Innovation to Converged Security Across Europe

businesswire.com · 29 Jul 2026

Primion and Iveda Partner to Bring AI Vision Innovation to Converged Security Across Europe

MESA, Ariz.--(BUSINESS WIRE)--Iveda® (NASDAQ: IVDA) a global leader in video intelligence solutions, today announced a new partnership with Primion, a global market leader in converged security and workforce management solutions, serving thousands of customers across Europe and beyond. Under the agreement, IvedaAI is now available as a standalone solution through Primion, with a longer-term roadmap to deepen the integration natively within Primion's converged security ecosystem. This collaborat.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.